Aclaris Therapeutics (ACRS) EPS (Basic) (2014 - 2026)
Aclaris Therapeutics (ACRS) posted quarterly EPS (Basic) of -$0.29 for Q1 2026, down 92.51% year-over-year from -$3.89 in Q1 2025, and down 13.82% quarter-over-quarter from -$0.26 in Q4 2025.
Aclaris Therapeutics (ACRS) EPS (Basic) (2014 - 2026) Analysis & Trends
Aclaris Therapeutics' EPS (Basic) history runs 13 years deep, the most recent figure standing at -$0.29 for Q1 2026.
- In Q1 2026, EPS (Basic) fell 92.51% year-over-year to -$0.29; the TTM figure through Mar 2026 stood at -$0.83 (up 31.37% YoY), while the FY2025 annual figure was -$2.23, down 30.35% from the prior year.
- EPS (Basic) for Q1 2026 stood at -$0.29, down from -$0.26 in the prior quarter.
- The five-year high for EPS (Basic) was -$0.14 in Q3 2024, with the low at -$2.82 in Q4 2023.
- The 5-year median for EPS (Basic) is -$0.47 (2023), against an average of -$0.57.
- The sharpest annual moves came in 2023 and 2025: EPS (Basic) sank 320.14% in 2023, then surged 81.76% in 2025.
- Aclaris Therapeutics' EPS (Basic) stood at -$0.67 in 2022, then tumbled by 320.14% to -$2.82 in 2023, then jumped by 50.35% to -$1.4 in 2024, then soared by 81.76% to -$0.26 in 2025, then slipped by 13.82% to -$0.29 in 2026.
- Business Quant data shows ACRS's EPS (Basic) at -$0.29 in Q1 2026, -$0.26 in Q4 2025, and -$0.16 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 4.34 |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 12.62 |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 7.59 |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | -3.06 |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 0.16 |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 0.00 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 0.18 |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 1.23 |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -0.06 |
| 10 | Aclaris Therapeutics | 808.18 Mn | 716.63 Mn | 1.41 Mn | -0.38 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -0.38 |
| Mar 31, 2026 | -0.29 |
| Dec 31, 2025 | -0.26 |
| Sep 30, 2025 | -0.16 |
| Jun 30, 2025 | -0.15 |
| Mar 31, 2025 | -0.15 |
| Dec 31, 2024 | -1.40 |
| Sep 30, 2024 | -0.14 |
| Jun 30, 2024 | -0.16 |
| Mar 31, 2024 | -0.25 |
| Dec 31, 2023 | -2.82 |
| Sep 30, 2023 | -0.47 |
| Jun 30, 2023 | -0.55 |
| Mar 31, 2023 | -0.51 |
| Dec 31, 2022 | -0.67 |
| Sep 30, 2022 | -0.55 |
| Jun 30, 2022 | -0.49 |
| Mar 31, 2022 | -0.62 |
| Dec 31, 2021 | -0.65 |
| Sep 30, 2021 | -0.63 |